Literature DB >> 1786621

A mathematical model for Plasmodium vivax malaria transmission: estimation of the impact of transmission-blocking immunity in an endemic area.

A P De Zoysa1, C Mendis, A C Gamage-Mendis, S Weerasinghe, P R Herath, K N Mendis.   

Abstract

We have developed a multi-state mathematical model to describe the transmission of Plasmodium vivax malaria; the model accommodates variable transmission-blocking/enhancing immunity during the course of a blood infection, a short memory for boosting immunity, and relapses. Using the model, we simulated the incidence of human malaria, sporozoite rates in the vector population, and the level of transmission-blocking immunity for the infected population over a period of time. Field data from an epidemiological study conducted in Kataragama in the south of Sri Lanka were used to test the results obtained. The incidence of malaria during the study period was simulated satisfactorily. The impact of naturally-acquired transmission-blocking immunity on malaria transmission under different vectorial capacities was also simulated. The results show that at low vectorial capacities, e.g., just above the threshold for transmission, the effect of transmission-blocking immunity is very significant; however, the effect is lower at higher vectorial capacities.

Entities:  

Mesh:

Year:  1991        PMID: 1786621      PMCID: PMC2393321     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  11 in total

1.  Successful immunization against the sexual stages of Plasmodium gallinaceum.

Authors:  R W Gwadz
Journal:  Science       Date:  1976-09-17       Impact factor: 47.728

2.  Modulation of human malaria transmission by anti-gamete transmission blocking immunity.

Authors:  A P de Zoysa; P R Herath; T A Abhayawardana; U K Padmalal; K N Mendis
Journal:  Trans R Soc Trop Med Hyg       Date:  1988       Impact factor: 2.184

3.  A metropolitan hospital in a non-endemic area provides a sampling pool for epidemiological studies on vivax malaria in Sri Lanka.

Authors:  J Fonseka; K N Mendis
Journal:  Trans R Soc Trop Med Hyg       Date:  1987       Impact factor: 2.184

4.  Monoclonal and polyclonal antibodies both block and enhance transmission of human Plasmodium vivax malaria.

Authors:  J S Peiris; S Premawansa; M B Ranawaka; P V Udagama; Y D Munasinghe; M V Nanayakkara; C P Gamage; R Carter; P H David; K N Mendis
Journal:  Am J Trop Med Hyg       Date:  1988-07       Impact factor: 2.345

5.  Plasmodium cynomolgi: serum-mediated blocking and enhancement of infectivity to mosquitoes during infections in the natural host, Macaca sinica.

Authors:  T D Naotunne; K D Rathnayake; A Jayasinghe; R Carter; K N Mendis
Journal:  Exp Parasitol       Date:  1990-10       Impact factor: 2.011

6.  Characteristics of malaria transmission in Kataragama, Sri Lanka: a focus for immuno-epidemiological studies.

Authors:  C Mendis; A C Gamage-Mendis; A P De Zoysa; T A Abhayawardena; R Carter; P R Herath; K N Mendis
Journal:  Am J Trop Med Hyg       Date:  1990-04       Impact factor: 2.345

7.  Malaria transmission blocked by immunisation with gametes of the malaria parasite.

Authors:  R Carter; D H Chen
Journal:  Nature       Date:  1976-09-02       Impact factor: 49.962

8.  Boosting of transmission-blocking immunity during natural Plasmodium vivax infections in humans depends upon frequent reinfection.

Authors:  M B Ranawaka; Y D Munesinghe; D M de Silva; R Carter; K N Mendis
Journal:  Infect Immun       Date:  1988-07       Impact factor: 3.441

9.  Malaria transmission-blocking immunity induced by natural infections of Plasmodium vivax in humans.

Authors:  K N Mendis; Y D Munesinghe; Y N de Silva; I Keragalla; R Carter
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

10.  The dynamics of malaria.

Authors:  G Macdonald; C B Cuellar; C V Foll
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

View more
  8 in total

1.  Risk analysis of the re-emergence of Plasmodium vivax malaria in Japan using a stochastic transmission model.

Authors:  Tomoyuki Bitoh; Kaoru Fueda; Hiroshi Ohmae; Mamoru Watanabe; Hirofumi Ishikawa
Journal:  Environ Health Prev Med       Date:  2010-10-26       Impact factor: 3.674

2.  A Multiscale Mathematical Model of Plasmodium Vivax Transmission.

Authors:  Md Nurul Anwar; Roslyn I Hickson; Somya Mehra; James M McCaw; Jennifer A Flegg
Journal:  Bull Math Biol       Date:  2022-07-01       Impact factor: 3.871

3.  Modeling Plasmodium vivax: relapses, treatment, seasonality, and G6PD deficiency.

Authors:  Farida Chamchod; John C Beier
Journal:  J Theor Biol       Date:  2012-08-29       Impact factor: 2.691

4.  Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission.

Authors:  Michael T White; Stephan Karl; Katherine E Battle; Simon I Hay; Ivo Mueller; Azra C Ghani
Journal:  Elife       Date:  2014-11-18       Impact factor: 8.140

5.  Plasmodium vivax readiness to transmit: implication for malaria eradication.

Authors:  Swamy Rakesh Adapa; Rachel A Taylor; Chengqi Wang; Richard Thomson-Luque; Leah R Johnson; Rays H Y Jiang
Journal:  BMC Syst Biol       Date:  2019-01-11

6.  Using observed incidence to calibrate the transmission level of a mathematical model for Plasmodium vivax dynamics including case management and importation.

Authors:  Clara Champagne; Maximilian Gerhards; Justin Lana; Bernardo García Espinosa; Christina Bradley; Oscar González; Justin M Cohen; Arnaud Le Menach; Michael T White; Emilie Pothin
Journal:  Math Biosci       Date:  2021-12-07       Impact factor: 2.144

7.  The potential elimination of Plasmodium vivax malaria by relapse treatment: insights from a transmission model and surveillance data from NW India.

Authors:  Manojit Roy; Menno J Bouma; Edward L Ionides; Ramesh C Dhiman; Mercedes Pascual
Journal:  PLoS Negl Trop Dis       Date:  2013-01-10

8.  The distribution of incubation and relapse times in experimental human infections with the malaria parasite Plasmodium vivax.

Authors:  Andrew A Lover; Xiahong Zhao; Zheng Gao; Richard J Coker; Alex R Cook
Journal:  BMC Infect Dis       Date:  2014-10-04       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.